SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-137039
Filing Date
2020-05-08
Accepted
2020-05-08 08:48:30
Documents
71
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d895430d10q.htm   iXBRL 10-Q 2153052
2 EX-31.1 d895430dex311.htm EX-31.1 10090
3 EX-31.2 d895430dex312.htm EX-31.2 10143
4 EX-32 d895430dex32.htm EX-32 4649
10 GRAPHIC g895430dsp01.jpg GRAPHIC 7524
  Complete submission text file 0001193125-20-137039.txt   8892476

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vivo-20200331.xsd EX-101.SCH 44554
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vivo-20200331_cal.xml EX-101.CAL 52287
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vivo-20200331_def.xml EX-101.DEF 245606
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vivo-20200331_lab.xml EX-101.LAB 383607
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vivo-20200331_pre.xml EX-101.PRE 341416
25 EXTRACTED XBRL INSTANCE DOCUMENT d895430d10q_htm.xml XML 2093386
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-14902 | Film No.: 20858890
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences